SUBSCRIBE
SUBSCRIBE

Asia

Up To 1 Billion People At Risk Of Blindness By 2050, Brien Holden Vision Institute Reveals
October 13, 2015
 · 
3 min read
It’s Official: A Glass Of Red Wine With Dinner Can Improve Heart Health In Diabetics, According To Ben-Gurion University of the Negev Researchers
October 13, 2015
 · 
4 min read
University of Sydney Scientists Pave Way For Diamonds To Trace Early Cancers
October 12, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Eli Lilly, China-based Innovent Biologics Expand Cancer Drug Collaboration With $1 Billion PD-1 Pact
October 12, 2015
 · 
3 min read
Diet Supplement Keeps Circadian Clock From Slowing Down In Aging Mice, Weizmann Institute of Science Study
October 9, 2015
 · 
1 min read
University of Queensland Scientists Grow Mini-Kidney In Lab
October 8, 2015
 · 
1 min read
Nurse Reused Syringes While Giving Flu Shots
October 8, 2015
 · 
1 min read
Business
Pluristem Therapeutics CEO Zami Aberman Elected To Board Of Directors Of The Alliance For Regenerative Medicine
October 7, 2015
 · 
1 min read
Trapping Cells That Tumors Release Allows Fast And Sensitive Genetic Analysis, A*STAR Study
October 7, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Clal Biotech Opts Out of Re-Acquiring Andromeda from Hyperion After Phase III Diabetes Drug Tanks
October 7, 2015
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China
January 23, 2026
 · 
2 min read
Press Releases
Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.
January 23, 2026
 · 
4 min read
Press Releases
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 23, 2026
 · 
4 min read
Press Releases
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
January 22, 2026
 · 
3 min read
Press Releases
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
January 22, 2026
 · 
3 min read
Press Releases
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
January 22, 2026
 · 
10 min read
Press Releases
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position
January 21, 2026
 · 
5 min read
Press Releases
ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges
January 21, 2026
 · 
2 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 21, 2026
 · 
5 min read
Press Releases
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
January 21, 2026
 · 
3 min read
Press Releases
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
January 21, 2026
 · 
4 min read
Press Releases
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1
January 20, 2026
 · 
7 min read
Press Releases
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
January 20, 2026
 · 
6 min read
Press Releases
Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
January 20, 2026
 · 
4 min read
Press Releases
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
January 20, 2026
 · 
6 min read
Press Releases
LexBio Named One of Ten “Honored Enterprises” in NVIDIA Inception Showcase 2025
January 19, 2026
 · 
1 min read
Press Releases
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene’s NouvNeu001, Making It the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
January 19, 2026
 · 
5 min read
Press Releases
Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis
January 19, 2026
 · 
4 min read
Press Releases
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
January 19, 2026
 · 
10 min read
Press Releases
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
January 19, 2026
 · 
7 min read
Load More